1. Home
  2. WIMI vs XLO Comparison

WIMI vs XLO Comparison

Compare WIMI & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WiMi Hologram Cloud Inc.

WIMI

WiMi Hologram Cloud Inc.

HOLD

Current Price

$2.85

Market Cap

37.4M

Sector

Technology

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.65

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIMI
XLO
Founded
2015
2016
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.4M
41.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
WIMI
XLO
Price
$2.85
$0.65
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
76.0K
528.0K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.43
N/A
Revenue
$61,329,146.00
$31,804,000.00
Revenue This Year
N/A
$589.60
Revenue Next Year
N/A
$38.00
P/E Ratio
$2.03
N/A
Revenue Growth
N/A
588.40
52 Week Low
$2.24
$0.62
52 Week High
$9.66
$1.70

Technical Indicators

Market Signals
Indicator
WIMI
XLO
Relative Strength Index (RSI) 40.15 32.70
Support Level $2.77 $0.64
Resistance Level $3.26 $0.73
Average True Range (ATR) 0.17 0.04
MACD 0.02 -0.01
Stochastic Oscillator 32.08 9.46

Price Performance

Historical Comparison
WIMI
XLO

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: